LACTOVIVE- lactobacillus acidophilus, bifidobacterium animalis lactis capsule

LactoVive by

Drug Labeling and Warnings

LactoVive by is a Other medication manufactured, distributed, or labeled by Lifsa Drugs LLC. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

HEALTH CLAIM

72336-172-30

PROBIOTIC SUPPORT

DIETARY SUPPLEMENT

DISPENSED BY PRESCRIPTION

DESCRIPTION

LactoVive is an orally administered prescription probiotic dietary supplement.

STATEMENT OF IDENTITY

Supplement Facts
Serving size 1 Capsule
Amount per Serving:		% Daily Value
* Daily value not established
Lactobacillus Acidophilus	16 Billion	*
Bifidobacterium Animalis Lactis	15 Billion	*

Inactive Ingredients:

Vegetable Capsules

Hydroxypropyl Methylcellulose, Silicon Dioxide, Magnesium Stearate.

Preservative Free and Gluten Free

INDICATIONS

LactoVive is an orally administered prescription probiotic formulation for the clinical dietary management of suboptimal nutritional status in patients where advanced supplementation is required and nutritional supplementation in physiologically stressful conditions for maintenance of good health is needed. LactoVive should be administered under the supervision of a licensed medical practitioner.

CONTRAINDICATIONS

This product is contraindicated in patients with a known hypersensitivity to any of the ingredients.

WARNING

LactoVive should only be used under the direction and supervision of a licensed medical practitioner. Use with caution in patients that may have a medical condition, are pregnant, lactating, trying to conceive, under the age of 18, or taking other medications.

ADVERSE REACTIONS

You should call your doctor for medical advice about serious adverse events. To report adverse side effects or to obtain product information, contact Lifsa Drugs, LLC at 1-800-FDA-1088

DOSAGE AND ADMINISTRATION

Usual adult dose is 1 capsule once or twice daily or as prescribed by a licensed medical practitioner.

HOW SUPPLIED

Bottle of 30 capsules (72336-172-30)

STORAGE AND HANDLING

Store 15°-30°C (59°-86°F) [See USP Controlled Room Temperature.] Avoid excessive heat, light, moisture and exceeding 85% humidity. Keep in a cool, dry place.

TAMPER EVIDENT: Do not use if seal is broken or missing.

HEALTH CLAIM

31 Billion CFU's verified at the time of production.

Manufactured For:

Lifsa Drugs, LLC

New Brunswick NJ 08901

MADE IN USA

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any diseases.

KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN

PRINCIPAL DISPLAY PANEL - 30 Capsule Bottle Label

72336-172-30

Lactobacillus Acidophilus
Bifidobacterium Animalis Lactis
31 Billion CFU's
30 CAPSULES

INGREDIENTS AND APPEARANCE

LACTOVIVE 
lactobacillus acidophilus, bifidobacterium animalis lactis capsule

Product Information
Product Type	DIETARY SUPPLEMENT	Item Code (Source)	NHRIC:72336-172
Route of Administration	ORAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
LACTOBACILLUS ACIDOPHILUS (UNII: 1PRR1V42V5) (LACTOBACILLUS ACIDOPHILUS - UNII:1PRR1V42V5)	LACTOBACILLUS ACIDOPHILUS	16000000000 [CFU]
BIFIDOBACTERIUM ANIMALIS LACTIS (UNII: 5307V7XW8I) (BIFIDOBACTERIUM ANIMALIS LACTIS - UNII:5307V7XW8I)	BIFIDOBACTERIUM ANIMALIS LACTIS	15000000000 [CFU]

Inactive Ingredients
Ingredient Name	Strength
HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO)
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
MAGNESIUM STEARATE (UNII: 70097M6I30)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NHRIC:72336-172-30	30 in 1 BOTTLE

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Dietary Supplement		02/25/2025

Supplement Facts
Serving Size :		Serving per Container :
	Amount Per Serving	% Daily Value
color
scoring	1
shape
size (solid drugs)	23 mm

Labeler - Lifsa Drugs LLC (081205160)